Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta

Summary

The primary objective of the study is to evaluate the effect of setrusumab on reduction in fracture rate, including morphometric vertebral fractures.

Timeline

Start

2024-10-25

Primary completion

2027-01

Completion

2028-01

Drugs

Indications